From the Laboratory to the Frontier of Human Health: How Dr. Ko-Cheng Fang Is Rewriting the Rules of Cancer Treatment with Plant-Based Nanotechnology and Precision Medicine

In the long and often brutal history of cancer treatment, the dominant philosophy has been one of controlled destruction — using radiation, chemotherapy, and surgery to eliminate tumors while hoping the patient survives the ordeal. Decades of research have yielded incremental progress, but the toll on the human body has remained devastating. For millions of patients worldwide, the side effects of conventional cancer therapy can be as life-altering as the disease itself. Into this landscape steps Dr. Ko-Cheng Fang, Founder, Chairman, and CEO of LongServing Technology, with a radically different proposition: what if we could eliminate cancer cells with precision, using compounds derived from nature, without destroying the body in the process?

Dr. Fang’s path to biotechnology did not begin in a hospital. It began in the world of cybersecurity. Early in his career, he developed patented technologies covering cloud storage systems and programmable password locks — innovations that were adopted by the United States Department of Homeland Security, contributing to foundational advancements in cloud computing and information security. That same instinct for solving problems others had declared unsolvable would later carry him into cancer research, jadeite synthesis, and quantum computing. Each domain was entered not because it was convenient, but because it was necessary.

It was during this period of broad technological development that Dr. Fang also pioneered the creation of laboratory-grown Imperial Green jadeite. This achievement — dismissed as impossible by General Electric and leading Chinese research institutions before him — required enduring thousands of failures in furnace conditions exceeding 1,400 degrees Celsius. The discipline of iterative learning under extreme conditions that jadeite demanded would later inform how he approached every other research challenge, including cancer. He learned to listen to the materials and the science, to observe patterns in failure, and to trust that the correct path existed even when no one else believed it did.

Dr. Fang’s entry into cancer research was shaped by a question he refused to abandon: is it possible to find plant extracts — singly or in combination — that could defeat cancer cells while leaving healthy cells entirely unharmed? Rather than accepting the prevailing framework of fighting poison with poison, he screened thousands of Eastern and Western medicinal herbs, applying nanotechnology and advanced solvents to develop formulations with both lipid-soluble and water-soluble properties, optimised for absorption by human cells. From the outset, he deliberately excluded any plant extract known to carry toxicity.

The technical breakthrough that makes this approach viable is a probe-based local delivery system capable of injecting therapeutic compounds directly into tumor cells. Rather than flooding the entire body with cytotoxic agents, the medicine is placed precisely where it is needed. In vitro experiments conducted by LongServing Technology demonstrated effective elimination of human liver cancer cells, lung cancer cells, and malignant melanoma cell lines — with healthy cells left undisturbed. Based on laboratory results, cancer cells can be eliminated within approximately three days of treatment, and if cancer spreads or recurs, the injection can be administered locally again without the need for major surgery.

The same period of intensive research that produced this biotechnology also yielded Dr. Fang’s most ambitious scientific achievement to date: the development of X-Photon, a photonic quantum material capable of emitting light at a wavelength of just 2 nanometers. Designed for nanoscale photonic pathways, photonic transistors, and next-generation photonic quantum chips, X-Photon has been described as a Nobel Prize-level invention of profound scientific significance. The photonic chip architecture it enables is protected by patents spanning 26 countries and offers speeds at least 1,000 times faster than conventional semiconductor chips, with dramatically lower energy consumption and carbon emissions.

Further advancing this photonic platform, Dr. Fang is also developing photonic memory — a technology that fundamentally eliminates the need for repeated light-to-electrical and electrical-to-light conversions, while enabling data buffering and temporary storage. When combined with photonic chips, this memory architecture could push computational speeds to at least 10,000 times faster than current electronic CPUs. The foundation of this entire breakthrough, as Dr. Fang has emphasised, is X-Photon materials: without this substance, such advancements would not be possible for humanity. He has also completed the development of a 7-nanometer photomask for photonic chip fabrication, a milestone that brings commercial-scale manufacturing within practical reach.

The implications of his cancer research extend well beyond laboratory results. Dr. Fang envisions a future in which treatment is dramatically more affordable and accessible — built on a model of low-toxicity plant compounds cultivated through contracted organic farming and delivered via minimally invasive probe injection. LongServing Technology warmly welcomes hospitals and research institutions to collaborate on clinical trials and further research exchange. For a technology that began as a single determined question posed in the face of conventional wisdom, the momentum is unmistakable. Dr. Ko-Cheng Fang has stepped into the arena — and he intends to win.

Dr. Ko-Cheng Fang

• Founder, CEO & Chairman
• LongServing Technology Co., Ltd
• Email: service@longserving.com.tw
• Website: https://longserving.com.tw/en/
• Instagram: @ko_cheng_fang_david